HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts.

AbstractBACKGROUND:
The oncosuppressive properties of some autonomous parvoviruses such as H-1 virus, together with their low pathogenicity, make them attractive vectors for tumor-directed gene therapy. Indeed, it was recently shown that these viruses became endowed with an enhanced oncosuppressive activity after they had been engineered to deliver a recognized therapeutic transgene. This prompted us to use a parvoviral vector to analyse the antineoplastic capacity of MCP-3 (monocyte chemotactic protein-3), a CC chemokine which has a broad spectrum of target cells, and can thus be considered to be a promising candidate for cancer treatment.
METHODS:
We explored the use of a parvovirus H-1-based vector encoding human MCP-3 for its antitumor potential on human cervical carcinoma cells. HeLa cells were infected in vitro with the recombinant virus hH1/MCP-3 at a low multiplicity [1 replication unit (RU)/cell] and we investigated the effect of parvovirus-mediated MCP-3 transduction on tumor formation and growth upon implantation of HeLa cells in nude mice.
RESULTS:
Infection of HeLa cells with hH1/MCP-3 led to secretion of high levels of MCP-3 and to significant retardation of tumor growth in recipient mice, as compared with HeLa cells that were either buffer-treated or infected with a MCP-3-free vector. Tumors from hH1/MCP-3-infected HeLa cells were heavily infiltrated with activated macrophages and showed increased numbers of dendritic cells. In addition, activated natural killer (NK) cells were also recruited into MCP-3-transduced tumors.
CONCLUSION:
These observations indicate that parvovirus H-1-transduced MCP-3 is able to exert a significant antitumor activity which is mediated, at least in part, through macrophages and NK cells, under conditions in which activated T cells are lacking.
AuthorsK Wetzel, P Menten, G Opdënakker, J Van Damme, H J Gröne, N Giese, A Vecchi, S Sozzani, J J Cornelis, J Rommelaere, C Dinsart
JournalThe journal of gene medicine (J Gene Med) 2001 Jul-Aug Vol. 3 Issue 4 Pg. 326-37 ISSN: 1099-498X [Print] England
PMID11529662 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CCL7 protein, human
  • Ccl7 protein, mouse
  • Chemokine CCL7
  • Cytokines
  • Monocyte Chemoattractant Proteins
  • Recombinant Proteins
Topics
  • Animals
  • Chemokine CCL7
  • Cytokines
  • Female
  • HeLa Cells
  • Humans
  • Mice
  • Mice, Nude
  • Monocyte Chemoattractant Proteins (genetics, pharmacokinetics, therapeutic use)
  • Parvovirus (genetics)
  • Plasmids
  • Recombinant Proteins (analysis)
  • Transcription, Genetic
  • Transduction, Genetic
  • Transplantation, Heterologous
  • Uterine Cervical Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: